PD-L1 28-8 pharmDx by IHC w/Interp, nivolumab (OPDIVO)
Order Name
PD-L1 28-8 IHC
Test Number: 6906285
Revision Date 05/07/2024
Test Number: 6906285
Revision Date 05/07/2024
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
PD-L1 28-8 pharmDx by IHC w/Interp, nivolumab (OPDIVO)
|
Immunohistochemistry |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | Tumor Tissue | Paraffin Block | Room Temperature | |
| Instructions | Notes: Three unstained tissue slides Specimen Type: Tissue block or slide Specimen Storage: Room temperature. Specimen Collection: Tissue should be fixed in 10% neutral buffered formalin for no more than 72 hours. Embed in paraffin. Special Instructions: NOTE: This test number is used for tracking oncology IHC specimens to the laboratory. Bill codes will be added when testing is complete, based on the processes performed in the laboratory. Causes for Rejection: Insufficient tissue; tumor other than non-small-cell lung cancer. |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 5-9 days |
| Performing Labcorp Test Code | 480588 |
| Lab Section | Reference Lab |